SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-053540
Filing Date
2023-05-01
Accepted
2023-05-01 07:55:59
Documents
22

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tm232155d2_def14a.htm   iXBRL DEF 14A 1816391
6 GRAPHIC bc_netsales-4c.jpg GRAPHIC 73438
7 GRAPHIC lc_cumtsr-4clr.jpg GRAPHIC 263292
8 GRAPHIC lc_netincome-4clr.jpg GRAPHIC 225231
9 GRAPHIC lc_relativetsr-4clr.jpg GRAPHIC 191681
10 GRAPHIC lg_intercept-4c.jpg GRAPHIC 27147
11 GRAPHIC px_01page-bw.jpg GRAPHIC 629887
12 GRAPHIC px_02page-bw.jpg GRAPHIC 635020
13 GRAPHIC sg_jeromedurso-bw.jpg GRAPHIC 27166
  Complete submission text file 0001104659-23-053540.txt   7651950

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA icpt-20221231.xsd EX-101.SCH 9883
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20221231_def.xml EX-101.DEF 7381
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20221231_lab.xml EX-101.LAB 18629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20221231_pre.xml EX-101.PRE 9690
16 EXTRACTED XBRL INSTANCE DOCUMENT tm232155d2_def14a_htm.xml XML 237567
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35668 | Film No.: 23870072
SIC: 2834 Pharmaceutical Preparations